Orgenesis (STU:45O) Other Stockholders Equity : €-0.00 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Other Stockholders Equity?

Orgenesis's Other Stockholders Equity for the quarter that ended in Dec. 2023 was €-0.00 Mil.

Orgenesis's quarterly Other Stockholders Equity declined from Jun. 2023 (€0.00 Mil) to Sep. 2023 (€0.00 Mil) and declined from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€-0.00 Mil).

Orgenesis's annual Other Stockholders Equity increased from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€0.00 Mil) but then declined from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€-0.00 Mil).

Orgenesis Other Stockholders Equity Historical Data

The historical data trend for Orgenesis's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Other Stockholders Equity Chart

Orgenesis Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

Orgenesis Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

Orgenesis Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Orgenesis Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Orgenesis's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Orgenesis (STU:45O) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (STU:45O) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ORGS:USA 45O:Germany

Address

20271 Goldenrod Lane, Germantown, MD, USA, 20876

Website

https://www.orgenesis.com

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis (STU:45O) Headlines

No Headlines